Abstract:Toll-like receptors (TLRs) belong to the Toll–interleukin 1 receptor superfamily, which is defined by a common intracellular Toll-IL-1 receptor (TIR) domain. A group of TIR domain containing adaptors (MyD88, TIRAP, TRIF and TRAM), are differentially recruited to the Toll-IL-1 receptors, contributing to the specificity of signaling. The IL-1 mediated signaling pathway serves as a “prototype” for other family members. Genetic and biochemical studies reveal that IL-1R uses adaptor molecule MyD88 to mediate a very complex pathway, involving a cascade of kinases organized by multiple adapter molecules into signaling complexes, leading to activation of the transcription factor NFκB. Several Toll-like receptors utilize variations of the “prototype” pathway by employing different adaptor molecules. Double-stranded RNA triggered, TLR3-mediated signaling is independent of MyD88, IRAK4, and IRAK. The adapter molecule TRIF is utilized by TLR3 to mediate the activation of NFκB and IRF3. LPS-induced, TLR4-mediated signaling employs multiple TIR-domain containing adaptors, MyD88/TIRAP to mediate NFκB activation, TRIF/TRAM for IRF3 activation. Recent studies have also begun to unravel how these pathways are negatively regulated. SIGIRR (also known as TIR8), a member of TIR superfamily that does not activate the transcription factors NFκB and IRF3, instead negatively modulates responses. Cells from SIGIRR-null mice show enhanced activation in response to either IL-1 or certain Toll ligands. In addition to SIGIRR, several other negative regulators have been shown to inhibit the TIR signaling, including ST2, IRAKM, MyD88s, SOCS1, and Triad3A. The coordinated positive and negative regulation of the TIR signaling ensures the appropriate modulation of the innate and inflammatory responses

Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

TIR domain-containing adaptors define the specificity of TLR signaling

Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct …

Shp-2 Phosphatase Negatively Regulates The Trif Adaptor Protein-Dependent Type I Interferon And Proinflammatory Cytokine Production

Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4

TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway

TLR signaling pathways

Toll-like Receptor 3-Mediated Activation of NF-κB and IRF3 Diverges at Toll-IL-1 Receptor Domain-Containing Adapter Inducing IFN-β

Modulation of Toll–interleukin 1 receptor mediated signaling

Toll like receptor 3 mediated activation of NF κB and IRF3 diverges at Toll IL 1 receptor domain containing adapter inducing IFN β

Toll-like receptor downstream signaling

Differential involvement of IFN‐β in Toll‐like receptor‐stimulated dendritic cell activation

TIRP, a Novel Toll/Interleukin-1 Receptor (TIR) Domain-containing Adapter Protein Involved in TIR Signaling

Microbial recognition by Toll-like receptors

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

Analysis of a TIR-less Splice Variant of TRIF Reveals an Unexpected Mechanism of TLR3-mediated Signaling

TLR3-Dependent Activation of TLR2 Endogenous Ligands Via the MyD88 Signaling Pathway Augments the Innate Immune Response

LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF

Recruitment of TLR adapter TRIF to TLR4 signaling complex is mediated by the second helical region of TRIF TIR domain

Mechanisms of the TRIF-induced Interferon-stimulated Response Element and NF-κB Activation and Apoptosis Pathways